In summary, the present study validated that Rb2 ameliorated IR via the inhibition of pyroptosis in 3T3-L1 adipocytes and EAT through the NF-κB pathway, providing a novel potential therapeutic approach to ameliorate IR in obesity. The gene discussed is NFKB1; the disease is obesity disorder.